XPF Antibody (OTI3H7) [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-74882APC
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse
Applications
CyTOF-ready, Flow Cytometry, Western Blot
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI3H7
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for XPF Antibody (OTI3H7) [Allophycocyanin]
Immunogen
Full length recombinant protein of human XPF (NP_005227) produced in HEK293T cells.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for XPF Antibody (OTI3H7) [Allophycocyanin]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: XPF
Long Name
Xeroderma Pigmentosum F
Alternate Names
ERCC4
Gene Symbol
ERCC4
Additional XPF Products
Product Documents for XPF Antibody (OTI3H7) [Allophycocyanin]
Product Specific Notices for XPF Antibody (OTI3H7) [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...